Merck group from Germany held its 90th anniversary celebration of the start of its operation in China

By Chen Ke

On 5 July, news came from the 90th anniversary celebration event of the start of its operation in China held by Merck group from Germany that the group has invested about 5.5 billion yuan in China in the past ten years, among which the investment in Nantong reached 2.8 billion yuan, which is more than half.

Merck group from Germany was founded in 1668. It focuses on three major businesses which are medical and health, life science and electronic technology. It has developed for 90 years in China. It has 20 registered companies in places including Beijing, Shanghai, Hong Kong, Wuxi, Suzhou and Nantong.

In January 2014, Merck group built Merck Pharmaceutical (Jiangsu) Co., Ltd., the second largest pharmaceutical base of the group in the world, in Nantong Economic & Technological Development Area. In the next following years, it continued to increase investment and expand industry, planning the layout in medical and health, and life science industries actively in Nantong, invested in total 5 major projects, the accumulated investment exceeded 2.8 billion yuan.

In the end of June, Merck Investment (China) Co., Ltd. signed with Nantong Economic & Technological Development Area again, planning to invest about 70 million euros to build Merck Life Science Center High Purity Reagent Production Base, which has broad application space in product quality control and test in fields including pharmaceutical, food and beverages.